| 000 | 01664 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516085007.0 | ||
| 264 | 0 | _c20130227 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1756-0500 | ||
| 024 | 7 |
_a10.1186/1756-0500-5-178 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDidych, Dmitry A | |
| 245 | 0 | 0 |
_aDNA fragments binding CTCF in vitro and in vivo are capable of blocking enhancer activity. _h[electronic resource] |
| 260 |
_bBMC research notes _cApr 2012 |
||
| 300 |
_a178 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCCCTC-Binding Factor |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aCricetulus |
| 650 | 0 | 4 |
_aCytomegalovirus _xgenetics |
| 650 | 0 | 4 |
_aDNA _xgenetics |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aEnhancer Elements, Genetic _xgenetics |
| 650 | 0 | 4 |
_aGanciclovir _xpharmacology |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeomycin _xpharmacology |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aRepressor Proteins _xgenetics |
| 650 | 0 | 4 |
_aSimplexvirus _xenzymology |
| 650 | 0 | 4 |
_aThymidine Kinase _xgenetics |
| 650 | 0 | 4 |
_aTransfection _xmethods |
| 700 | 1 | _aKotova, Elena S | |
| 700 | 1 | _aAkopov, Segey B | |
| 700 | 1 | _aNikolaev, Lev G | |
| 700 | 1 | _aSverdlov, Eugene D | |
| 773 | 0 |
_tBMC research notes _gvol. 5 _gp. 178 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1756-0500-5-178 _zAvailable from publisher's website |
| 999 |
_c21682500 _d21682500 |
||